Assistant Professor, Internal Medicine, Mayo Medical School
Oncology
Dr. Thai H. Ho, MD
|
|
Give Review
Thai works in the field of Oncology. He went to Baylor College of Medicine. He received awards:"Young Investigator Award" and "Paul Calabresi Career Development Award (K12)". Thai has written publications. He has 26 publications published with PubMed. The lastest paper is: 'Predictors of incipient dysfunction of all cardiac chambers after treatment of metastatic renal cell carcinoma by tyrosine kinase inhibitors.' Doctor Thai H. Ho, MD accepts Medicare.
Publications
- Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of Renal cell carcinoma-specific death.
- PD-1 and PD-L1 Expression in Renal Cell Carcinoma With Sarcomatoid Differentiation.
- Clear cell Renal cell carcinoma subtypes identified by BAP1 and PBRM1 expression.
- A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.
- Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal Cancer cell lines.
- High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic Renal cell carcinoma.
- The impact of FGFR1 and FRS2alpha expression on sorafenib treatment in metastatic Renal cell carcinoma.
- Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized...
- Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression Analysis.
- Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell Renal cell carcinoma.
- Loss of PBRM1 and BAP1 expression is less common in non-clear cell Renal cell carcinoma than in clear cell Renal cell carcinoma.
- PD-L1 Expression in Non-clear cell Renal Cell Carcinoma.
- Genetic Kidney Cancer Syndromes.
- Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human Cancer cells.
- Perioperative complications after neoadjuvant chemotherapy and radical cystectomy for bladder Cancer.
- Inverse Association between Programmed Death Ligand 1 and Genes in the VEGF Pathway in Primary Clear Cell Renal Cell Carcinoma.
- Variation in chromatin accessibility in human kidney Cancer links H3K36 methyltransferase loss with widespread RNA processing defects.
- Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell Renal cell carcinoma.
- Simple mimetics of a nuclear localization signal (NLS).
- The mechanism of inhibition of Ran-dependent nuclear transport by cellular ATP depletion.
- Axitinib in the treatment of metastatic Renal cell carcinoma.
- Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
- Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.
- Muscleblind proteins regulate alternative splicing.
- Predictors of incipient dysfunction of all cardiac chambers after treatment of metastatic Renal cell carcinoma by tyrosine kinase inhibitors.
Schools
Baylor Coll Of Med
Conditions Treated
- Acute Leukemia
- AdRenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Young Investigator Award
- Paul Calabresi Career Development Award (K12)
Education
-
University of Texas MD Anderson Cancer Center -
Washington University - Barnes-Jewish Hospital -
Baylor College of Medicine
Hospital
-
Mayo Clinic - Phoenix/Scottsdale, Arizona
Drug Facts
| NPI NUMBER | 1326054115 | |
| NPPES Provider LastName | HO | |
| NPPES Provider FirstName | THAI | |
| NPPES Provider ZIPCode | 852595452 | |
| NPPES Provider State | AZ | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 237.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 4.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326054115 |
| Last Name Of The Provider | HO |
| First Name Of The Provider | THAI |
| View All |
Similar Doctors
|
|
Dr. Giraldo Kato, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip J. Federio, MD |
|
|
Dr. Mitesh J. Borad, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alan H. Bryce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald W. Northfelt, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Peter A. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas H. Robinson, MD |
|
|
Dr. Nandita Khera, MD
This Doctor is OpenDoctor Recommended.
|